LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China flag China · Delayed Price · Currency is CNY
7.34
-0.17 (-2.26%)
Nov 13, 2026, 3:04 PM CST

SHE:002644 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
653.52524.49397.89406.04397.85374.94
Trading Asset Securities
----2-
Cash & Short-Term Investments
653.52524.49397.89406.04399.85374.94
Cash Growth
45.66%31.82%-2.01%1.55%6.64%-17.06%
Accounts Receivable
411.43474.08413.57382.65435.88344.8
Other Receivables
8.3219.4145.5950.562.9812.34
Receivables
419.75493.49459.17433.15498.87357.14
Inventory
310.6289.84339.99369.72363.26258.83
Prepaid Expenses
-0.120.040.9--
Other Current Assets
56.2924.7924.7929.064243.72
Total Current Assets
1,4401,3331,2221,2391,3041,035
Property, Plant & Equipment
965.17986.961,0321,0621,0681,092
Long-Term Investments
64.0769.9355.6664.168.6771.65
Goodwill
9.019.019.019.019.014.47
Other Intangible Assets
71.1373.5576.8779.5576.7971.96
Long-Term Deferred Tax Assets
63.8465.7961.8153.6553.9851.11
Long-Term Deferred Charges
1.761.843.767.6560.89
Other Long-Term Assets
7.017.668.7813.4320.4125.76
Total Assets
2,6222,5472,4702,5282,6062,352

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
350.19263.63213.09310.37314.47214.3
Accrued Expenses
1.5519.0210.2111.4628.869.9
Short-Term Debt
9.2821.71010--
Current Portion of Long-Term Debt
1.3614.713.9213.8913.414.2
Current Portion of Leases
-1.390.820.80.870.5
Current Income Taxes Payable
12.88.519.0827.4244.7444.26
Current Unearned Revenue
51.3350.7516.0547.0299.9335.91
Other Current Liabilities
62.5460.9396.5646.7440.2855.78
Total Current Liabilities
489.04440.62379.73467.69542.54374.84
Long-Term Debt
8.26.21526.640.3753.14
Long-Term Leases
2.841.511.051.350.970.81
Long-Term Unearned Revenue
226.52241.4256.1260.96278.15294.96
Long-Term Deferred Tax Liabilities
2.882.32.933.073.180.85
Total Liabilities
729.49692.03654.81759.67865.21724.59

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
510.66510.66510.66510.66510.66510.66
Additional Paid-In Capital
337.39337.39337.39337.38352.33343.51
Retained Earnings
1,024983.95940.88896.13854.47758.78
Comprehensive Income & Other
0.540.660.961.211.61.62
Total Common Equity
1,8731,8331,7901,7451,7191,615
Minority Interest
19.622.7925.0923.0622.1712.92
Shareholders' Equity
1,8931,8551,8151,7681,7411,628
Total Liabilities & Equity
2,6222,5472,4702,5282,6062,352

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
21.6845.4940.7952.6355.668.65
Net Cash (Debt)
631.84479357.1353.41344.26306.29
Net Cash Growth
51.63%34.13%1.04%2.66%12.39%-12.86%
Net Cash Per Share
1.240.940.700.690.670.60
Filing Date Shares Outstanding
510.81510.66510.66510.66510.66510.66
Total Common Shares Outstanding
510.81510.66510.66510.66510.66510.66
Working Capital
951.12892.12842.16771.18761.43659.79
Book Value Per Share
3.673.593.513.423.373.16
Tangible Book Value
1,7931,7501,7041,6571,6331,538
Tangible Book Value Per Share
3.513.433.343.243.203.01
Buildings
-946.04945.9938.67933.74927.81
Machinery
-382.57377.02366.31333.01317.82
Construction In Progress
--1.763.3--